Back to Agenda
ST00: Current Status of Clinical Development for Depression. -Issues, Lesson Learns, Solutions-
Session Chair(s)
Marika Uchida
Undergraduate
Meiji Pharmaceutical University, School of Pharmacy, Japan
Moeka Yamanoi
Undergraduate
Meiji Pharmaceutical University, School of Pharmacy, Japan
Yuni Shimbori
School of Pharmacy
Nihon University, Japan
Speaker(s)
Tetsuo Nakabayashi, MD, PhD
Office of Medical Informatics and Epidemiology
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Motoki Arakawa, PhD
Junior Associate Professor, School of Pharmacy
Nihon University , Japan
Katsuhiko Ichimaru
Review Director, Office of New Drug IV
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Hideki Maeda, PhD
Professor, Department of Regulatory Science
Meiji Pharmaceutical University, Japan
Jun Yamakami, PhD
Senior Manager, R&D Regulatory 1, Regulatory Affairs
Sanofi K.K., Japan
Saki Watanabe
Monitoring Group
Pfizer R&D Japan G.K., Japan
Ryohei Sato, MS
Department of Clinical Research and Development
Otsuka Pharmaceutical Co., Ltd., Japan
Minami Mori
CRA, Clinical Operations
IQVIA Services Japan K.K., Japan
Have an account?